Parkinson's Disease - Epidemiology Forecast to 2028

Publisher Name :
Date: 15-Jan-2019
No. of pages: 50
Delivery of the Report will take 2-3 working days once order is placed.

DelveInsight's "Parkinson's Disease - Epidemiology Forecast, 2028" report provides a comprehensive analysis of the Parkinson's Disease epidemiology, providing the historical and forecasted data for the 7MM during the forecast period from 2016-2028.

Markets Covered

- United States

- EU5 (Germany, France, Italy, Spain, and the United Kingdom)

- Japan

Study Period: 2016-2028

Parkinson's Disease Epidemiology

The epidemiology section covers the historical, current as well as forecasted epidemiology for Parkinson's Disease in 7 major markets. The data is collected by understanding the disease, reviewing numerous studies conducted by countries and by exploring different surveys as well as reports. The Key opinion leaders' views are also taken into account to provide a deep understanding of the Parkinson's Disease outlook. It also includes the explanation of changing trends of epidemiology outlining the Parkinson's Disease scenario.

Parkinson's Disease Epidemiology Segmentation

The epidemiology section is further segmented according to the patient pool characteristics, such as age-specific, type-specific, sub-type specific, gender-specific etc., thus providing an in-depth and high-quality analysis. The report also covers the prevalent/Incidence cases as well as the treatable cases as per the therapies available for the Parkinson's Disease thereby presenting the trends with detailed analysis, with the assumptions undertaken. The data is presented in the form of graphs along with tables to effectively summarize the landscape.

Report Scope

- The report covers detailed overview of Parkinson's Disease explaining its causes, symptoms, classification, pathophysiology, diagnosis and treatment patterns

- It provides the insight about the historical and forecasted patient pool for 7 major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan

- The Parkinson's Disease Report assesses the disease risk and burden and highlights the unmet needs

- It also helps to recognize the growth opportunities in the 7MM with respect to the patient population

Key strengths

- 10 Year Forecast

- 7MM Coverage

- Total Cases in Parkinson's Disease

Key assessments

- Patient Segmentation in Parkinson's Disease

- Parkinson's Disease Risk & Burden

- Factors driving growth in a specific Parkinson's Disease patient population

Parkinson's Disease - Epidemiology Forecast to 2028

Table of Contents

1. Report Introduction
2. Parkinson's Disease Epidemiology Overview at a Glance
2.1. Patient Share Distribution of Parkinson's Disease in 2016
2.2. Patient Share Distribution of Parkinson's Disease in 2028
3. Disease Background and Overview: Parkinson's Disease
3.1. Introduction
3.2. Symptoms
3.3. Etiology
3.4. Risk Factors
3.5. Pathophysiology
3.6. Diagnosis
3.7. Treatment
4. Epidemiology and Patient Population
4.1. Key Findings
4.2. Total Prevalent/ Incident Patient Population of Parkinson's Disease in 7MM
4.3. Total Prevalent/ Incident Patient Population of Parkinson's Disease in 7MM - By Countries
5. Epidemiology of Parkinson's Disease by Countries
5.1. United States
5.1.1. Assumptions and Rationale
5.1.2. Prevalent/Incident Cases of the Parkinson's Disease
5.1.3. Sub-Type Specific cases of the Parkinson's Disease *
5.1.4. Sex- Specific Cases of the Parkinson's Disease *
5.1.5. Diagnosed Cases of the Parkinson's Disease
5.2. EU5
5.3. Assumptions and Rationale
5.4. Germany
5.4.1. Assumptions and Rationale
5.4.2. Prevalent/Incident Cases of the Parkinson's Disease
5.4.3. Sub-Type Specific cases of the Parkinson's Disease *
5.4.4. Sex- Specific Cases of the Parkinson's Disease *
5.4.5. Diagnosed Cases of the Parkinson's Disease
5.5. France
5.5.1. Assumptions and Rationale
5.5.2. Prevalent/Incident Cases of the Parkinson's Disease
5.5.3. Sub-Type Specific cases of the Parkinson's Disease *
5.5.4. Sex- Specific Cases of the Parkinson's Disease *
5.5.5. Diagnosed Cases of the Parkinson's Disease
5.6. Italy
5.6.1. Assumptions and Rationale
5.6.2. Prevalent/Incident Cases of the Parkinson's Disease
5.6.3. Sub-Type Specific cases of the Parkinson's Disease *
5.6.4. Sex- Specific Cases of the Parkinson's Disease *
5.6.5. Diagnosed Cases of the Parkinson's Disease
5.7. Spain
5.7.1. Assumptions and Rationale
5.7.2. Prevalent/Incident Cases of the Parkinson's Disease
5.7.3. Sub-Type Specific cases of the Parkinson's Disease *
5.7.4. Sex- Specific Cases of the Parkinson's Disease *
5.7.5. Diagnosed Cases of the Parkinson's Disease
5.8. United Kingdom
5.8.1. Assumptions and Rationale
5.8.2. Prevalent/Incident Cases of the Parkinson's Disease
5.8.3. Sub-Type Specific cases of the Parkinson's Disease *
5.8.4. Sex- Specific Cases of the Parkinson's Disease *
5.8.5. Diagnosed Cases of the Parkinson's Disease
5.9. Japan
5.9.1. Assumptions and Rationale
5.9.2. Prevalent/Incident Cases of the Parkinson's Disease
5.9.3. Sub-Type Specific cases of the Parkinson's Disease *
5.9.4. Sex- Specific Cases of the Parkinson's Disease *
5.9.5. Diagnosed Cases of the Parkinson's Disease
6. Unmet Needs of the Parkinson's Disease
7. Appendix
8. Report Methodology
8.1. Sources
9. DelveInsight Capabilities
10. Disclaimer
11. About DelveInsight
*Indication Specific

List of Tables

Table 1: Total Prevalent/Incident Cases of the Parkinson's Disease in 7MM
Table 2: Total Prevalent/Incident Cases of the Parkinson's Disease in 7MM by Countries
Table 3: Prevalent/Incident Cases of the Parkinson's Disease in United States (2016-2028)
Table 4: Sub-Type Specific cases of the Parkinson's Disease in United States (2016-2028)*
Table 5: Sex- Specific Cases of the Parkinson's Disease in United States (2016-2028)*
Table 6: Diagnosed Cases of the Parkinson's Disease in United States (2016-2028)
Table 7: Prevalent/Incident Cases of the Parkinson's Disease in Germany (2016-2028)
Table 8: Sub-Type Specific cases of the Parkinson's Disease in Germany (2016-2028) *
Table 9: Sex- Specific Cases of the Parkinson's Disease in Germany (2016-2028) *
Table 10: Diagnosed Cases of the Parkinson's Disease in Germany (2016-2028)
Table 11: Prevalent/Incident Cases of the Parkinson's Disease in France (2016-2028)
Table 12: Sub-Type Specific cases of the Parkinson's Disease in France (2016-2028) *
Table 13: Sex- Specific Cases of the Parkinson's Disease in France (2016-2028) *
Table 14: Diagnosed Cases of the Parkinson's Disease in France (2016-2028)
Table 15: Prevalent/Incident Cases of the Parkinson's Disease in Italy (2016-2028)
Table 16: Sub-Type Specific cases of the Parkinson's Disease in Italy (2016-2028) *
Table 17: Sex- Specific Cases of the Parkinson's Disease in Italy (2016-2028) *
Table 18: Diagnosed Cases of the Parkinson's Disease in Italy (2016-2028)
Table 19: Prevalent/Incident Cases of the Parkinson's Disease in Spain (2016-2028)
Table 20: Sub-Type Specific cases of the Parkinson's Disease in Spain (2016-2028) *
Table 21: Sex- Specific Cases of the Parkinson's Disease in Spain (2016-2028) *
Table 22: Diagnosed Cases of the Parkinson's Disease in Spain (2016-2028)
Table 23: Prevalent/Incident Cases of the Parkinson's Disease in UK (2016-2028)
Table 24: Sub-Type Specific cases of the Parkinson's Disease in UK (2016-2028) *
Table 25: Sex- Specific Cases of the Parkinson's Disease in UK (2016-2028) *
Table 26: Diagnosed Cases of the Parkinson's Disease in UK (2016-2028)
Table 27: Prevalent/Incident Cases of the Parkinson's Disease in Japan (2016-2028)
Table 28: Sub-Type Specific cases of the Parkinson's Disease in Japan (2016-2028) *
Table 29: Sex- Specific Cases of the Parkinson's Disease in Japan (2016-2028) *
Table 30: Diagnosed Cases of the Parkinson's Disease in Japan (2016-2028)

List of Figures

Figure 1: Total Prevalent/Incident Cases of the Parkinson's Disease in 7MM
Figure 2: Total Prevalent/Incident Cases of the Parkinson's Disease in 7MM by Countries
Figure 3: Prevalent/Incident Cases of the Parkinson's Disease in United States (2016-2028)
Figure 4: Sub-Type Specific cases of the Parkinson's Disease in United States (2016-2028)*
Figure 5: Sex- Specific Cases of the Parkinson's Disease in United States (2016-2028)*
Figure 6: Diagnosed Cases of the Parkinson's Disease in United States (2016-2028)
Figure 7: Prevalent/Incident Cases of the Parkinson's Disease in Germany (2016-2028)
Figure 8: Sub-Type Specific cases of the Parkinson's Disease in Germany (2016-2028) *
Figure 9: Sex- Specific Cases of the Parkinson's Disease in Germany (2016-2028) *
Figure 10: Diagnosed Cases of the Parkinson's Disease in Germany (2016-2028)
Figure 11: Prevalent/Incident Cases of the Parkinson's Disease in France (2016-2028)
Figure 12: Sub-Type Specific cases of the Parkinson's Disease in France (2016-2028) *
Figure 13: Sex- Specific Cases of the Parkinson's Disease in France (2016-2028) *
Figure 14: Diagnosed Cases of the Parkinson's Disease in France (2016-2028)
Figure 15: Prevalent/Incident Cases of the Parkinson's Disease in Italy (2016-2028)
Figure 16: Sub-Type Specific cases of the Parkinson's Disease in Italy (2016-2028) *
Figure 17: Sex- Specific Cases of the Parkinson's Disease in Italy (2016-2028) *
Figure 18: Diagnosed Cases of the Parkinson's Disease in Italy (2016-2028)
Figure 19: Prevalent/Incident Cases of the Parkinson's Disease in Spain (2016-2028)
Figure 20: Sub-Type Specific cases of the Parkinson's Disease in Spain (2016-2028) *
Figure 21: Sex- Specific Cases of the Parkinson's Disease in Spain (2016-2028) *
Figure 22: Diagnosed Cases of the Parkinson's Disease in Spain (2016-2028)
Figure 23: Prevalent/Incident Cases of the Parkinson's Disease in UK (2016-2028)
Figure 24: Sub-Type Specific cases of the Parkinson's Disease in UK (2016-2028) *
Figure 25: Sex- Specific Cases of the Parkinson's Disease in UK (2016-2028) *
Figure 26: Diagnosed Cases of the Parkinson's Disease in UK (2016-2028)
Figure 27: Prevalent/Incident Cases of the Parkinson's Disease in Japan (2016-2028)
Figure 28: Sub-Type Specific cases of the Parkinson's Disease in Japan (2016-2028) *
Figure 29: Sex- Specific Cases of the Parkinson's Disease in Japan (2016-2028) *
Figure 30: Diagnosed Cases of the Parkinson's Disease in Japan (2016-2028)

  • Global Parkinson's Disease Therapeutics Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 99
    Parkinson's disease (PD), or simply Parkinson's, is a chronic degenerative disorder of The central nervous system that affects both The motor system and non-motor systems. The symptoms usually emerge slowly, and as The disease worsens, non-motor symptoms become more common. Early symptoms are tremor, rigidity, slowness of movement, and difficulty with walking. Problems may also arise with cognition, behaviour, sleep, and sensory systems. Parkinson's disease dementia becomes common in advanced st......
  • Global Amantadine Hydrochloride Market Insights, Forecast to 2029
    Published: 29-Aug-2023        Price: US 4900 Onwards        Pages: 109
    Amantadine hydrochloride (CAS 665-66-7), C10H18ClN, the formula weight is 187.71, and its form is white crystal powder. The global Amantadine Hydrochloride market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual Growth Rate (CAGR) of % during the forecast period. Amantadine hydrochloride is clinically effective in preventing and treating infections of various influenza A viruses. In the influenza epidemic period, this product is use......
  • Global Rasagiline Tablet Market Insights, Forecast to 2029
    Published: 11-Aug-2023        Price: US 4900 Onwards        Pages: 107
    Rasagiline (Azilect, Azipron) is an irreversible inhibitor of monoamine oxidase-B used as a monotherapy to treat symptoms in early Parkinson's disease or as an adjunct therapy in more advanced cases. The global Rasagiline Tablet market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual Growth Rate (CAGR) of % during the forecast period. The racemic form of the drug was invented by Aspro Nicholas in the early 1970s. Moussa B.H. Youdim identifi......
  • Global Parkinsons Disease Drug Market Insights, Forecast to 2029
    Published: 02-Aug-2023        Price: US 4900 Onwards        Pages: 113
    Most people with Parkinson's disease eventually need a medication called levodopa. Levodopa is absorbed by the nerve cells in your brain and turned into the chemical dopamine, which is used to transmit messages between the parts of the brain and nerves that control movement. The global Parkinsons Disease Drug market is projected to grow from US$ 5763.6 million in 2023 to US$ 7419.9 million by 2029, at a Compound Annual Growth Rate (CAGR) of 4.3% during the forecast period. Global P......
  • Global Rasagiline Tablet Market Research Report 2023, Forecast to 2028
    Published: 20-Mar-2023        Price: US 2680 Onwards        Pages: 137
    Rasagiline is used alone or with other medications (such as levodopa/carbidopa) to treat symptoms of Parkinson's disease. It can help improve symptoms such as shakiness, stiffness, and difficulty moving. It can also help reduce the amount of "off" time (periods of slow movement or stiffness). Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data fo......
  • Global Rasagiline Tablet Professional Survey Report 2023, Forecast to 2028
    Published: 20-Mar-2023        Price: US 3280 Onwards        Pages: 109
    Rasagiline is used alone or with other medications (such as levodopa/carbidopa) to treat symptoms of Parkinson's disease. It can help improve symptoms such as shakiness, stiffness, and difficulty moving. It can also help reduce the amount of "off" time (periods of slow movement or stiffness). Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data fo......
  • Global Amantadine Hydrochloride Market Research Report 2023
    Published: 09-Mar-2023        Price: US 2900 Onwards        Pages: 98
    Amantadine hydrochloride (CAS 665-66-7), C10H18ClN, the formula weight is 187.71, and its form is white crystal powder. Highlights The global Amantadine Hydrochloride market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes. Amantadine hydrochloride is clinically effective......
  • Global Parkinson's Disease (PD) Drugs Professional Survey Report 2023, Forecast to 2028
    Published: 21-Feb-2023        Price: US 3280 Onwards        Pages: 133
    Levodopa, the most effective Parkinson's disease medication, is a natural chemical that passes into your brain and is converted to dopamine. Levodopa is combined with carbidopa (Lodosyn), which protects levodopa from early conversion to dopamine outside your brain. This prevents or lessens side effects such as nausea. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market v......
  • Global Parkinson's Disease (PD) Drugs Market Research Report 2023, Forecast to 2028
    Published: 21-Feb-2023        Price: US 2680 Onwards        Pages: 159
    Levodopa, the most effective Parkinson's disease medication, is a natural chemical that passes into your brain and is converted to dopamine. Levodopa is combined with carbidopa (Lodosyn), which protects levodopa from early conversion to dopamine outside your brain. This prevents or lessens side effects such as nausea. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market v......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs